369 related articles for article (PubMed ID: 8335369)
1. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice.
Tesh VL; Burris JA; Owens JW; Gordon VM; Wadolkowski EA; O'Brien AD; Samuel JE
Infect Immun; 1993 Aug; 61(8):3392-402. PubMed ID: 8335369
[TBL] [Abstract][Full Text] [Related]
2. The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.
Lindgren SW; Samuel JE; Schmitt CK; O'Brien AD
Infect Immun; 1994 Feb; 62(2):623-31. PubMed ID: 8300218
[TBL] [Abstract][Full Text] [Related]
3. Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model.
Lindgren SW; Melton AR; O'Brien AD
Infect Immun; 1993 Sep; 61(9):3832-42. PubMed ID: 8359904
[TBL] [Abstract][Full Text] [Related]
4. Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice.
Melton-Celsa AR; Darnell SC; O'Brien AD
Infect Immun; 1996 May; 64(5):1569-76. PubMed ID: 8613362
[TBL] [Abstract][Full Text] [Related]
5. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II.
Wadolkowski EA; Sung LM; Burris JA; Samuel JE; O'Brien AD
Infect Immun; 1990 Dec; 58(12):3959-65. PubMed ID: 2254023
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.
Samuel JE; Perera LP; Ward S; O'Brien AD; Ginsburg V; Krivan HC
Infect Immun; 1990 Mar; 58(3):611-8. PubMed ID: 2155181
[TBL] [Abstract][Full Text] [Related]
7. Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric Shiga-like toxin type II operons.
Paton AW; Bourne AJ; Manning PA; Paton JC
Infect Immun; 1995 Jul; 63(7):2450-8. PubMed ID: 7790056
[TBL] [Abstract][Full Text] [Related]
8. Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages.
Tesh VL; Ramegowda B; Samuel JE
Infect Immun; 1994 Nov; 62(11):5085-94. PubMed ID: 7927791
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay.
Perera LP; Marques LR; O'Brien AD
J Clin Microbiol; 1988 Oct; 26(10):2127-31. PubMed ID: 3053764
[TBL] [Abstract][Full Text] [Related]
10. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies.
Donohue-Rolfe A; Acheson DW; Kane AV; Keusch GT
Infect Immun; 1989 Dec; 57(12):3888-93. PubMed ID: 2807552
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of the Shiga-like toxin produced by Escherichia coli associated with porcine edema disease.
Gannon VP; Gyles CL
Vet Microbiol; 1990 Jul; 24(1):89-100. PubMed ID: 2219668
[TBL] [Abstract][Full Text] [Related]
12. Construction and characterization of an isogenic slt-ii deletion mutant of enterohemorrhagic Escherichia coli.
Gunzer F; Bohn U; Fuchs S; Mühldorfer I; Hacker J; Tzipori S; Donohue-Rolfe A
Infect Immun; 1998 May; 66(5):2337-41. PubMed ID: 9573126
[TBL] [Abstract][Full Text] [Related]
13. Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells.
Louise CB; Obrig TG
J Infect Dis; 1995 Nov; 172(5):1397-401. PubMed ID: 7594687
[TBL] [Abstract][Full Text] [Related]
14. Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli.
Sung LM; Jackson MP; O'Brien AD; Holmes RK
J Bacteriol; 1990 Nov; 172(11):6386-95. PubMed ID: 2228965
[TBL] [Abstract][Full Text] [Related]
15. Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity.
Perera LP; Samuel JE; Holmes RK; O'Brien AD
J Bacteriol; 1991 Feb; 173(3):1151-60. PubMed ID: 1991714
[TBL] [Abstract][Full Text] [Related]
16. Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits.
Sjogren R; Neill R; Rachmilewitz D; Fritz D; Newland J; Sharpnack D; Colleton C; Fondacaro J; Gemski P; Boedeker E
Gastroenterology; 1994 Feb; 106(2):306-17. PubMed ID: 8299898
[TBL] [Abstract][Full Text] [Related]
17. Effects of human intravenous immune globulin on diarrhea caused by Shiga-like toxin I and Shiga-like toxin II in infant rabbits.
Havens PL; Dunne WM; Burd EM
Microbiol Immunol; 1992; 36(10):1077-85. PubMed ID: 1479962
[TBL] [Abstract][Full Text] [Related]
18. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2).
Oku Y; Yutsudo T; Hirayama T; O'Brien AD; Takeda Y
Microb Pathog; 1989 Feb; 6(2):113-22. PubMed ID: 2654533
[TBL] [Abstract][Full Text] [Related]
19. Escherichia coli cytotoxins and enterotoxins.
Gyles CL
Can J Microbiol; 1992 Jul; 38(7):734-46. PubMed ID: 1393838
[TBL] [Abstract][Full Text] [Related]
20. Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies.
Downes FP; Barrett TJ; Green JH; Aloisio CH; Spika JS; Strockbine NA; Wachsmuth IK
Infect Immun; 1988 Aug; 56(8):1926-33. PubMed ID: 3294179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
